share_log

CLSA PREMIUM(06877)发布年度业绩,年度溢利984.2万港元,同比扭亏为盈

CLSA PREMIUM (06877) announced annual results, with an annual profit of HK$9.842 million, turning a year-on-year loss into a profit

Zhitong Finance ·  Mar 11 07:48

CLSA PREMIUM (06877) released Audited for the year ended December 31, 2023...

According to the Zhitong Finance App, CLSA PREMIUM (06877) released audited results for the year ended December 31, 2023. Total revenue from continuing operations was approximately HK$200 million, up 410.37% year on year; annual profit from continuing operations was HK$12.83 million, which turned a year-on-year loss into profit; annual profit of HK$9.842 million, while a loss of HK$31.052 million was recorded in the same period in 2022; profit of HK$0.48 per share.

According to reports, the increase in net profit was mainly due to significant growth in the health care business in 2023, and the revenue from sales of health products exceeded 3 times that of 2022.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment